Natco Pharma Limited Total Assets

Latest as of September 2025: Rs104.30 Billion INR ≈ $1.13 Billion USD

Natco Pharma Limited total assets. Based on the latest financial reports, Natco Pharma Limited (NATCOPHARM) holds total assets worth Rs104.30 Billion INR (≈ $1.13 Billion USD) as of September 2025. Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments. Also see market value of Natco Pharma Limited for the company's overall valuation and market capitalisation.

Total Assets of Natco Pharma Limited (2005–2025)

Total assets of Natco Pharma Limited from 2005 to 2025. This chart illustrates how Natco Pharma Limited's total assets have evolved over time, based on quarterly financial data. See NATCOPHARM live share price for real-time trading data and today's change.

Natco Pharma Limited - Asset Composition Analysis

Natco Pharma Limited Total Assets Breakdown (March 2025)

Natco Pharma Limited total assets breakdown as of March 2025. Natco Pharma Limited's total assets of Rs104.30 Billion consist of 61.1% current assets and 38.9% non-current assets.

Asset Category	Amount (INR)	% of Total Assets
Cash & Equivalents	Rs539.00 Million	25.2%
Accounts Receivable	Rs12.56 Billion	14.6%
Inventory	Rs7.66 Billion	8.9%
Property, Plant & Equipment	Rs26.57 Billion	30.8%
Intangible Assets	Rs2.09 Billion	2.4%
Goodwill	Rs574.00 Million	0.7%

Asset Composition Trend (2005–2025)

This chart illustrates how Natco Pharma Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution. Explore Natco Pharma Limited working capital to net assets to assess how much short-term liquidity the company maintains relative to its equity base.

Show as percentage

Key Asset Composition Facts

Current vs. Non-Current Assets: Natco Pharma Limited's current assets represent 61.1% of total assets in 2025, an increase from 56.2% in 2005.
Cash Position: Cash and equivalents constituted 25.2% of total assets in 2025, up from 16.1% in 2005.
Tangible vs. Intangible: Intangible assets (including goodwill) make up 2.0% of total assets, an increase from 0.0% in 2005.
Asset Diversification: The largest asset category is property, plant & equipment at 30.8% of total assets.

Natco Pharma Limited Competitors by Total Assets

Key competitors of Natco Pharma Limited based on total assets are shown below.

Company	Country	Total Assets
Richter Gedeon Vegyészeti Gyár Nyilvánosan Muködo Rt F:RIG2	Germany	€1.60 Trillion
Changchun High & New Technology Industries Group Inc SHE:000661	China	CN¥30.77 Billion
Chengdu Kanghong Pharmaceuticals Group Co Ltd SHE:002773	China	CN¥9.94 Billion
Zhejiang Hisun Pharmaceutical Co Ltd SHG:600267	China	CN¥13.81 Billion
Shenzhen Chipscreen Biosciences Co SHG:688321	China	CN¥3.63 Billion
Cronos Group Inc TO:CRON	Canada	CA$1.18 Billion
Jiangsu Kanion Pharmaceutical Co Ltd SHG:600557	China	CN¥6.74 Billion
HPGC Renmintongtai Pharmaceutical Corp SHG:600829	China	CN¥7.35 Billion

Natco Pharma Limited - Liquidity and Working Capital Analysis

Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.

Key Liquidity Metrics

Metric	Current	1 Year Ago	5 Years Ago
Current Ratio	4.10	4.96	3.06
Quick Ratio	3.62	4.19	2.30
Cash Ratio	1.58	1.55	0.00
Working Capital	Rs52.67 Billion	Rs39.93 Billion	Rs18.25 Billion

Natco Pharma Limited - Advanced Valuation Insights

This section examines the relationship between Natco Pharma Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.

Key Valuation Metrics

Current Price-to-Book Ratio	2.39
Latest Market Cap to Assets Ratio	0.02
Asset Growth Rate (YoY)	25.0%
Total Assets	Rs86.31 Billion
Market Capitalization	$1.56 Billion USD

Valuation Analysis

Below Book Valuation: The market values Natco Pharma Limited's assets below their book value (0.02x), which may indicate investor concerns about asset quality or future growth.

Rapid Asset Growth: Natco Pharma Limited's assets grew by 25.0% over the past year, indicating significant expansion of the company's resource base.

Annual Total Assets for Natco Pharma Limited (2005–2025)

The table below shows the annual total assets of Natco Pharma Limited from 2005 to 2025.

Year	Total Assets	Change
2025-03-31	Rs86.31 Billion ≈ $933.39 Million	+24.97%
2024-03-31	Rs69.06 Billion ≈ $746.89 Million	+22.08%
2023-03-31	Rs56.57 Billion ≈ $611.83 Million	+10.73%
2022-03-31	Rs51.09 Billion ≈ $552.53 Million	+6.62%
2021-03-31	Rs47.92 Billion ≈ $518.23 Million	+4.45%
2020-03-31	Rs45.88 Billion ≈ $496.15 Million	+6.62%
2019-03-31	Rs43.03 Billion ≈ $465.36 Million	+15.83%
2018-03-31	Rs37.15 Billion ≈ $401.77 Million	+60.30%
2017-03-31	Rs23.18 Billion ≈ $250.64 Million	+27.08%
2016-03-31	Rs18.24 Billion ≈ $197.24 Million	+31.77%
2015-03-31	Rs13.84 Billion ≈ $149.68 Million	+15.75%
2014-03-31	Rs11.96 Billion ≈ $129.31 Million	+10.67%
2013-03-31	Rs10.80 Billion ≈ $116.84 Million	+19.68%
2012-03-31	Rs9.03 Billion ≈ $97.63 Million	+27.63%
2011-03-31	Rs7.07 Billion ≈ $76.49 Million	+28.39%
2010-03-31	Rs5.51 Billion ≈ $59.58 Million	+6.66%
2009-03-31	Rs5.17 Billion ≈ $55.86 Million	+23.16%
2008-03-31	Rs4.19 Billion ≈ $45.36 Million	+19.89%
2007-03-31	Rs3.50 Billion ≈ $37.83 Million	+13.59%
2006-03-31	Rs3.08 Billion ≈ $33.30 Million	+7.15%
2005-03-31	Rs2.87 Billion ≈ $31.08 Million	--

About Natco Pharma Limited

NSE:NATCOPHARM India Drug Manufacturers - Specialty & Generic

Market Cap

$1.56 Billion

Rs144.54 Billion INR

Market Cap Rank

#6817 Global

#332 in India

Share Price

Rs807.00

Change (1 day)

+1.31%

52-Week Range

Rs781.60 - Rs1206.00

All Time High

Rs1591.09